Kindred Healthcare Receives Consensus Rating of “Buy” from Analysts (NYSE:KND)
Kindred Healthcare (NYSE:KND) has earned a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, American Banking News reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $28.50.
Shares of Kindred Healthcare (NYSE:KND) traded up 1.46% on Friday, hitting $20.22. 123,511 shares of the company’s stock traded hands. Kindred Healthcare has a 52 week low of $12.95 and a 52 week high of $26.81. The stock has a 50-day moving average of $23.29 and a 200-day moving average of $23.02. The company’s market cap is $1.307 billion.
Kindred Healthcare (NYSE:KND) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.34 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.32 by $0.02. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.28 billion. During the same quarter last year, the company posted $0.32 earnings per share. Kindred Healthcare’s revenue was up 7.1% compared to the same quarter last year. On average, analysts predict that Kindred Healthcare will post $1.09 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, September 10th. Stockholders of record on Wednesday, August 20th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.41%. The ex-dividend date of this dividend is Monday, August 18th.
Several analysts have recently commented on the stock. Analysts at Zacks downgraded shares of Kindred Healthcare from a “neutral” rating to an “underperform” rating in a research note on Thursday. They now have a $18.50 price target on the stock. Analysts at Craig Hallum initiated coverage on shares of Kindred Healthcare in a research note on Friday, May 23rd. They set a “buy” rating and a $25.00 price target on the stock.
Kindred Healthcare, Inc is a healthcare services company that through its subsidiaries operates transitional care (NYSE:KND) hospitals, inpatient rehabilitation hospitals (IRFs), nursing and rehabilitation centers, assisted living facilities, a contract rehabilitation services business and a home health and hospice business across the United States.
Receive News & Ratings for Kindred Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.